$4.12 (-1.67%)

Volume: 83.363k

Closed: Mar 24, 2023

Hollow Logo Score: -2.915
Capricor Therapeutics Stock
$4.12 (-1.67%)

Volume: 83.363k

Closed: Mar 24, 2023

Score Hollow Logo -2.915
NASDAQ:CAPR

Capricor Therapeutics Stock Signals

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -2.915 1 day ( 0 % )
Last Price $4.12 -1.67 %
High/ Low $4.06 - $4.27 0.246%
Chg 7 Days -5.07 % $4.34 $4.12
Chg 30 Days -4.19 % $4.30 $4.12
Chg 12 mos -22.70 % $5.33 $4.12
Trend - 3 mos 16.77 % Width: 27.48 %
Trend - 12 mos 13.43 % Width: 94.48 %
Pred. range - 3 mos $4.80 - $6.12 16.57 % - 48.61 %
Pred. range - 12 mos $4.03 - $7.85 -2.09 % - 90.42 %
Short mv avg 3 mos Sell 2023-03-06 - 15 days
Long mv avg 3 mos Sell 2023-03-16 - 7 days
Short/Long mv avg 3 mos Sell 2023-03-22 - 3 days
Short mv avg 12 mos Sell 2023-03-08 - 13 days
Long mv avg 12 mos Sell 2023-03-21 - 4 days
Short/Long mv avg 12 mos Buy 2023-03-02 - 17 days
Pivot Short Sell 2023-03-01 - 18 days
Bollinger Buy 2023-03-24 - 1 day
MACD Sell No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Capricor Therapeutics

Capricor Therapeutics Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Ph... CAPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT